Literature DB >> 14599853

Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood.

Dominique De Wit1, Sandrine Tonon, Véronique Olislagers, Stanislas Goriely, Michaël Boutriaux, Michel Goldman, Fabienne Willems.   

Abstract

Toll-like receptor (TLR)-4 signaling pathway plays an essential role in host defense against gram-negative bacteria while TLR-3-mediated signaling is critically involved in anti-viral immunity. To gain insight into the defects responsible for impaired Th1 responses in human newborns, we investigated the responses of human cord blood cells to lipopolysaccharide, LPS, and to polyinosinic-polycytidylic acid, Poly (I:C), ligands of TLR-4 and TLR-3, respectively. Measurement of cytokine levels revealed a profound defect in IL-12 (p70) synthesis and an increased release of IL-10 in cord blood exposed to LPS or Poly (I:C), as compared to adult blood. Moreover, Poly (I:C)-induced IFN-alpha production was found to be significantly impaired in cord blood. Phenotypic maturation of myeloid DC in response to LPS or Poly (I:C) was next compared in cord and adult blood. We observed that neonatal myeloid DC displayed decreased upregulation of CD40, CD80 whereas CD86 and HLA-DR upregulation did not differ significantly between adults and neonates. Taken together, these findings might be relevant to the increased vulnerability of human newborns to intracellular pathogens and to their inability to develop efficient Th1-type responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599853     DOI: 10.1016/j.jaut.2003.08.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  72 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry.

Authors:  Jeong-Ki Kim; Ghazi Kayali; David Walker; Heather L Forrest; Ali H Ellebedy; Yolanda S Griffin; Adam Rubrum; Mahmoud M Bahgat; M A Kutkat; M A A Ali; Jerry R Aldridge; Nicholas J Negovetich; Scott Krauss; Richard J Webby; Robert G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

3.  Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation.

Authors:  Darren Blimkie; Edgardo S Fortuno; Howard Yan; Patricia Cho; Kevin Ho; Stuart E Turvey; Arnaud Marchant; Stanislas Goriely; Tobias R Kollmann
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

4.  Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.

Authors:  Ofer Levy; Eugénie E Suter; Richard L Miller; Michael R Wessels
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 5.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

6.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries.

Authors:  A H J van den Biggelaar; P G Holt
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 7.  Defective antigen-presenting cell function in human neonates.

Authors:  Paula A Velilla; Maria T Rugeles; Claire A Chougnet
Journal:  Clin Immunol       Date:  2006-09-28       Impact factor: 3.969

8.  Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.

Authors:  Pascal M Lavoie; Qing Huang; Elyse Jolette; Mihoko Whalen; Anne Monique Nuyt; Francois Audibert; David P Speert; Thierry Lacaze-Masmonteil; Hugo Soudeyns; Tobias R Kollmann
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

9.  A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.

Authors:  Beth C Holbrook; Jong R Kim; Lance K Blevins; Matthew J Jorgensen; Nancy D Kock; Ralph B D'Agostino; S Tyler Aycock; Mallinath B Hadimani; S Bruce King; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

10.  Differential responses of cord and adult blood-derived dendritic cells to dying cells.

Authors:  On Hang Wong; Fang-Ping Huang; Alan K S Chiang
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.